ARL4C and pancreatic neoplasm: Because PI3 kinase is one of the direct effector proteins of RAS (Castellano and Downward, 2011; Rodriguez-Viciana et al., 1994), RAS-dependent PI3 kinase activation and ARL4C expression could co-operatively function to promote pancreatic cancer invasion.